Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Concentration and Activity of Lapatinib in Vestibular Schwannomas

NCT00863122

Conditions
Acoustic Neuroma, Auditory Tumor, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +31 more
Locations
  • House Reserach Institute Los Angeles, California, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University Medical Center St Louis, Missouri, United States
View Trial Details
Completed

Trial of pIL-12/MK-3475 in Metastatic Melanoma

NCT02493361

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of San Francisco, California San Francisco, California, United States
  • Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

NCT00446082

Conditions
Acromegaly, Adenocarcinoma, Bone Diseases, +18 more
Locations
  • Cedars Sinai Medical Center SC - 4 Los Angeles, California, United States
  • Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1) Tampa, Florida, United States
  • University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States
View all 17 locations
View Trial Details
Completed

A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

NCT01652547

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Lausanne, Switzerland
  • Novartis Investigative Site Zurich, Switzerland
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

NCT02308020

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +28 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
  • Univ of California San Francisco San Francisco, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 44 locations
View Trial Details

Related conditions